Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 11/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 11/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28012007 | 0.81 | MTNR1A (0.45) | MTNR1AMTNR1BHSD17B2HSD17B1CES2 | |
| SCHEMBL1779795 | 0.80 | MTNR1A (0.44) | MTNR1AMTNR1BHSD17B2HSD17B1CES2 | |
| SCHEMBL4288276 | 0.80 | PARP1 (0.44) | MTNR1AMTNR1BHSD17B2HSD17B1CES2 | |
| SCHEMBL27877846 | 0.80 | MTNR1A (0.44) | MTNR1AMTNR1BHSD17B2HSD17B1CES2 | |
| SCHEMBL1007582 | 0.80 | MTNR1A (0.44) | MTNR1AMTNR1BHSD17B2HSD17B1CES2 | |
| SCHEMBL4318019 | 0.76 | MTNR1A (0.39) | ALOX15MTNR1AMTNR1BHSD17B2HSD17B1 | |
| SCHEMBL4318013 | 0.76 | MTNR1A (0.39) | ALOX15MTNR1AMTNR1BHSD17B2HSD17B1 | |
| SCHEMBL4318553 | 0.74 | MTNR1A (0.38) | ALOX15MTNR1AMTNR1BHSD17B2HSD17B1 | |
| SCHEMBL4318558 | 0.74 | MTNR1A (0.38) | ALOX15MTNR1AMTNR1BHSD17B2HSD17B1 | |
| SCHEMBL10477183 | 0.73 | ALOX15 (0.52) | ALOX15MTNR1AMTNR1BHSD17B2HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-2558577-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | Nuevolution A/S (DK) | 2013-02-20 | — | — | EP | disclosed |
| WO-2011127933-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2011-10-20 | — | — | WO | disclosed |
| EP-1226119-B1 | TYROSINE KINASE INHIBITORS | MERCK & CO INC (US) | 2005-03-16 | — | — | EP | disclosed |
| EP-1226119-A4 | TYROSINE KINASE INHIBITORS | MERCK & CO INC (US) | 2003-04-09 | — | — | EP | disclosed |
| US-6479512-B1 | TO TREAT TYROSINE KINASE-DEPENDENT DISEASES AND CONDITIONS, SUCH AS ANGIOGENESIS, CANCER, TUMOR GROWTH, ATHEROSCLEROSIS, AGE RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY, INFLAMMATORY DISEASES, ETC. | MERCK & CO., INC. | 2002-11-12 | — | — | US | disclosed |
| EP-1226119-A2 | TYROSINE KINASE INHIBITORS | MERCK & CO. INC. (US) | 2002-07-31 | — | — | EP | disclosed |
| WO-2001028993-A2 | TYROSINE KINASE INHIBITORS | MERCK & CO. INC. (US) | 2001-04-26 | — | — | WO | disclosed |